![](/img/cover-not-exists.png)
LBA62Health-related quality of life (HRQoL) for pembrolizumab or placebo plus carboplatin and paclitaxel or nab-paclitaxel in patients with metastatic squamous NSCLC: Data from KEYNOTE-407
Mazières, J, Kowalski, D, Luft, A, Vicente, D, Tafreshi, A, Gümüş, M, Laktionov, K, Hermes, B, Cicin, I, Rodríguez-Cid, J, Wilson, J, Kato, T, Ramlau, R, Novello, S, Reddy, S, Piperdi, B, Li, X, BurkeVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy424.074
Date:
October, 2018
File:
PDF, 83 KB
english, 2018